[HTML][HTML] Exploring the Role of Noncoding RNAs in Cancer Diagnosis, Prognosis, and Precision Medicine.
B Eldakhakhny, AM Sutaih, MA Siddiqui… - Non-coding RNA …, 2024 - Elsevier
This review article studies the complex field of noncoding RNAs (ncRNAs) in cancer biology,
focusing on their potential use as biomarkers and therapeutic targets. ncRNAs include …
focusing on their potential use as biomarkers and therapeutic targets. ncRNAs include …
PSA Based Biomarkers, Imagistic Techniques and Combined Tests for a Better Diagnostic of Localized Prostate Cancer
VC Munteanu, RA Munteanu, D Gulei, VH Schitcu… - Diagnostics, 2020 - mdpi.com
Prostate cancer represents the most encountered urinary malignancy in males over 50 years
old, and the second most diagnosed after lung cancer globally. Digital rectal examination …
old, and the second most diagnosed after lung cancer globally. Digital rectal examination …
Grape Powder Supplementation Attenuates Prostate Neoplasia Associated with Pten Haploinsufficiency in Mice Fed High‐Fat Diet
Scope Previous studies have identified potent anticancer activities of polyphenols in
preventing prostate cancer. The aim of the current study is to evaluate the chemopreventive …
preventing prostate cancer. The aim of the current study is to evaluate the chemopreventive …
Evaluation of MicroRNAs as non-invasive diagnostic markers in urinary cells from patients with suspected prostate cancer
A Borkowetz, A Lohse-Fischer, J Scholze, U Lotzkat… - Diagnostics, 2020 - mdpi.com
Currently used tumor markers for early diagnosis of prostate cancer (PCa) are often lacking
sufficient specificity and sensitivity. Therefore, the diagnostic potential of selected …
sufficient specificity and sensitivity. Therefore, the diagnostic potential of selected …
Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate …
L Wu, W Quan, G Yue, Q Luo, D Peng, Y Pan, G Zhang - BMC cancer, 2021 - Springer
Background Autophagy is a highly conserved homeostatic process in the human body that is
responsible for the elimination of aggregated proteins and damaged organelles. Several …
responsible for the elimination of aggregated proteins and damaged organelles. Several …
miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer
S Choi, S Lee, YH Han, J Choi, I Kim, J Lee… - Frontiers in …, 2022 - frontiersin.org
MicroRNAs are key regulators of gene expression in tumorigenesis. In this study, we
investigated the tumor-suppressive function of miR-31-3p. Analysis of the Gene Expression …
investigated the tumor-suppressive function of miR-31-3p. Analysis of the Gene Expression …
Diagnostic properties of miR-146a-5p from liquid biopsies in prostate cancer: A meta-analysis
Z Dobrijević, J Stevanović, M Šunderić… - … -Research and Practice, 2024 - Elsevier
Background Several studies on biomarker properties of microRNAs from liquid biopsy in
prostate cancer (PCa) identified miR-146a-5p as a potential novel diagnostic marker …
prostate cancer (PCa) identified miR-146a-5p as a potential novel diagnostic marker …
Urine cell-free microRNAs in localized prostate cancer patients
Simple Summary Urine cell-free microRNAs (cfmiRs) are promising biomarkers for the
detection of prostate cancer (PCa) and may replace or complement prostate-specific antigen …
detection of prostate cancer (PCa) and may replace or complement prostate-specific antigen …
MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis
X Zhai, Y Wu, D Zhang, H Li, T Chong… - Journal of Bioenergetics …, 2021 - Springer
Renal cell carcinoma (RCC) is one of the most common renal malignancies in the urinary
system. Numerous studies have demonstrated that miRNAs can regulate tumorigenesis and …
system. Numerous studies have demonstrated that miRNAs can regulate tumorigenesis and …
Circulating miRNAs As Biomarkers for Early Disease Diagnosis
J Holdmann, A Savelsbergh, L Markert - miRNAs, Human Health and …, 2024 - Springer
In today's medical world, early detection of disease is a crucial factor in ensuring that
patients receive appropriate and adequate treatment. Particularly in the context of cancer …
patients receive appropriate and adequate treatment. Particularly in the context of cancer …